Masamichi Hayakawa Selected Research

Masamichi Hayakawa Research Topics

Disease

40	Neoplasms (Cancer) 04/2017 - 08/2002
21	Renal Cell Carcinoma (Grawitz Tumor) 04/2017 - 08/2002
14	Kidney Neoplasms (Kidney Cancer) 07/2009 - 08/2002
13	Prostatic Neoplasms (Prostate Cancer) 12/2013 - 03/2002
13	Neoplasm Metastasis (Metastasis) 01/2011 - 08/2002
5	Lymphatic Metastasis 09/2008 - 08/2004
3	Hydronephrosis 05/2011 - 01/2006
3	Fibrosis (Cirrhosis) 11/2010 - 12/2004
3	Pathologic Constriction (Stenosis) 11/2010 - 01/2005
3	Ureteral Obstruction 04/2010 - 03/2004
3	Obesity 02/2008 - 10/2006
2	Urinary Bladder Neoplasms (Bladder Cancer) 09/2013 - 02/2004
2	Intraoperative Complications 05/2011 - 12/2005
2	Hemorrhage 05/2011 - 12/2005
2	Lymphocele 05/2011 - 01/2008
2	Pheochromocytoma 12/2010 - 03/2009
2	Leiomyosarcoma 08/2009 - 01/2006
2	Carcinogenesis 05/2009 - 10/2006
2	Carcinoma (Carcinomatosis) 02/2008 - 01/2005
1	Thrombosis (Thrombus) 06/2011
1	Urethral Stricture 05/2011
1	Cardiac Arrhythmias (Arrythmia) 05/2011
1	Hernia (Hernias) 05/2011
1	Polyuria 12/2010
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2010
1	Fatigue 10/2010
1	Liver Diseases (Liver Disease) 10/2010
1	Ascites 10/2010
1	Cushing Syndrome 06/2009

Drug/Important Bio-Agent (IBA)

6	AntigensIBA 12/2007 - 10/2002
5	AndrogensIBA 12/2008 - 10/2002
4	SurvivinIBA 05/2009 - 04/2006
4	Liposomes (Liposome)IBA 03/2007 - 03/2004
3	Proteins (Proteins, Gene)FDA Link 01/2011 - 10/2006
3	Peptides (Polypeptides)IBA 12/2010 - 02/2004
3	Transforming Growth Factor beta (TGF-beta)IBA 04/2010 - 05/2003
3	Gefitinib (Iressa)FDA Link 07/2009 - 01/2004
3	Topotecan (Hycamtin)FDA LinkGeneric 05/2009 - 03/2007
3	Small Interfering RNA (siRNA)IBA 05/2009 - 03/2007
3	CytokinesIBA 11/2006 - 10/2006
2	Glucose (Dextrose)FDA LinkGeneric 01/2011 - 03/2009
2	ParaffinIBA 01/2011 - 08/2004
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2010 - 01/2006
2	Vincristine (Oncovin)FDA LinkGeneric 11/2010 - 01/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2010 - 01/2006
2	Hormones (Hormone)IBA 08/2009 - 01/2007
2	Fatty Acid Synthases (Fatty Acid Synthase)IBA 09/2008 - 08/2008
2	matrigelIBA 08/2008 - 10/2006
2	AntibodiesIBA 07/2008 - 02/2004
2	Messenger RNA (mRNA)IBA 04/2008 - 10/2006
2	Contrast MediaIBA 12/2007 - 03/2007
2	candesartanIBA 01/2007 - 08/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2007 - 08/2002
2	Angiotensin IIIBA 01/2007 - 08/2002
2	LeptinIBA 10/2006 - 10/2006
2	Monoclonal AntibodiesIBA 10/2006 - 03/2005
2	Leptin ReceptorsIBA 10/2006 - 10/2006
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2006 - 01/2004
2	Oxidoreductases (Dehydrogenase)IBA 12/2004 - 12/2004
2	LuciferasesIBA 04/2004 - 12/2002
2	Therapeutic UsesIBA 04/2004 - 10/2002
2	ErbB Receptors (EGF Receptor)IBA 02/2004 - 01/2004
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2004 - 03/2003
2	Protein Kinase CIBA 01/2004 - 03/2002
1	Biomarkers (Surrogate Marker)IBA 04/2017
1	Erythropoietin FDA Link 06/2012
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 06/2012
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2011
1	Formaldehyde (Formol)FDA Link 01/2011
1	MetanephrineIBA 12/2010
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2010
1	3-Iodobenzylguanidine (Iobenguane)IBA 12/2010
1	NormetanephrineIBA 12/2010
1	Atrial Natriuretic Factor (ANF)IBA 12/2010
1	Prednisolone (Predate)FDA LinkGeneric 11/2010
1	Rituximab (Mabthera)FDA Link 11/2010
1	poly(maleic acid-styrene)neocarzinostatin (zinostatin stimalamer)IBA 10/2010
1	maleic acid (maleate)IBA 10/2010
1	ZinostatinIBA 10/2010
1	Ethiodized Oil (Ethiodol)FDA Link 10/2010
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2010
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 04/2010
1	AdrenomedullinIBA 04/2010
1	Cisplatin (Platino)FDA LinkGeneric 08/2009
1	GlucocorticoidsIBA 06/2009
1	hexamethylene bisacetamide (HMBA)IBA 05/2009
1	Topoisomerase I InhibitorsIBA 05/2009
1	Indigo Carmine (Indigo Blue)IBA 04/2009

Therapy/Procedure

11	Therapeutics 10/2010 - 08/2002
5	Nephrectomy 06/2011 - 05/2003
3	Prostatectomy (Retropubic Prostatectomy) 12/2013 - 01/2008
3	Catheters 05/2011 - 01/2008
3	Drug Therapy (Chemotherapy) 11/2010 - 01/2006
2	Radiotherapy 08/2009 - 01/2005
2	Adrenalectomy 06/2009 - 05/2008
1	Cystectomy 09/2013
1	Operative Time 05/2011
1	Laparotomy 11/2010
1	Molecular Targeted Therapy 10/2010
1	Radiofrequency Ablation 08/2009